Impaired glucose transport into the brain: The expanding spectrum of glucose transporter type 1 deficiency syndrome

Current Opinion in Neurology

Volumn 17, Issue 2, 2004, Pages 193-196

  Klepper, Jörg ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Blood brain barrier; Epilepsy; Glucose transporter type 1; Glucose transporter type 1 deficiency syndrome; Glut1; Ketogenic diet; Ketosis; Seizures

Indexed keywords

ANTICONVULSIVE AGENT; ANTIOXIDANT; CARBAMAZEPINE; CHLORAL HYDRATE; DIAZEPAM; GLUCOSE TRANSPORTER 1; PHENOBARBITAL; PHENYTOIN; THIOCTIC ACID;

BRAIN DISEASE; BRAIN METABOLISM; DRUG CONTRAINDICATION; DRUG INDICATION; ELECTROENCEPHALOGRAM; ENERGY METABOLISM; EPILEPSY; GLUCOSE TRANSPORT; GLUCOSE TRANSPORT SYSTEM; GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME; HUMAN; KETOACIDOSIS; KETOGENIC DIET; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; REVIEW; SYNDROME DELINEATION;

ADULT; BLOOD GLUCOSE; BLOOD-BRAIN BARRIER; BRAIN; BRAIN DISEASES, METABOLIC, INBORN; CHILD; CHILD, PRESCHOOL; DEVELOPMENTAL DISABILITIES; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; ELECTROENCEPHALOGRAPHY; ENERGY METABOLISM; EPILEPSY; GLUCOSE TRANSPORTER TYPE 1; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; MONOSACCHARIDE TRANSPORT PROTEINS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 1842610160     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-200404000-00018     Document Type: Review

References (35)

1. De Vivo DC, Trifiletti RR, Jacobson RI, et al. Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med 1991; 325:703-709.
2. Joost HG, Thorens B. The extended GLUT-family of sugar/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members [review]. Mol Membr Biol 2001; 18:247-256.
3. Dwyer DS, Vannucci SJ, Simpson IA. Expression, regulation, and functional role of glucose transporters (GLUTs) in brain. Int Rev Neurobiol 2002; 51:159-188.
4. Wang D, Kranz-Eble P, De Vivo DC. Mutational analysis of GLUT1 (SLC2A1) in GLUT1 deficiency syndrome. Hum Mutat 2000; 16:224-231.
5. Klepper J, Wang D, Fischbarg J, et al. Defective glucose transport across brain tissue barriers: a newly recognized neurological syndrome. Neurochem Res 1999; 24:587-594.
6. Seidner G, Alvarez MG, Yeh JI, et al. GLUT1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier. Nat Genet 1998; 18:188-191.
7. Ho YY, Wang D, Hinton V, et al. GLUT1 deficiency syndrome (GLUT1-DS): autosomal dominant transmission of the R126C missense mutation [abstract]. Ann Neurol 2001; 50 (Suppl):S125.
8. Brockmann K, Wang D, Korenke CG, et al. Autosomal dominant GLUT1 deficiency syndrome and familial epilepsy. Ann Neurol 2001; 50:476-485.
9. Klepper J, Willemsen M, Verrips A, et al. Autosomal dominant transmission of GLUT1 deficiency. Hum Mol Genet 2001; 10:63-68.
10. Wang D, Pascual JM, Iserovich P, et al. Functional studies of threonine 310 mutations in GLUT1: T310I is pathogenic, causing GLUT1 deficiency. J Biol Chem 2003; 278:49015-49021.
11. Wang D, Ho YY, Pascual JM, et al. GLUT1 deficiency syndrome (GLUT1-DS): R333W genotype and paternal mosaicism [abstract]. Ann Neurol 2001; 50 (Suppl):S124.
12. Klepper J, De Vivo DC, Webb DW, et al. Reversible infantile hypoglycorrhachia: possible transient disturbance in glucose transport? Pediatr Neurol 2003; 29:321-325.
13. Overweg-Plandsoen WC, Groener JE, Wang D, et al. GLUT1 deficiency without epilepsy: an exceptional case. J Inherit Metab Dis 2003; 26:559-563.
14. Klepper J, Voit T. Facilitated glucose transporter protein type 1 (GLUT1) deficiency syndrome: impaired glucose transport into brain - a review. Eur J Pediatr 2002; 161:295-304.
15. von Moers A, Brockmann K, Wang D, et al. EEG features of GLUT1 deficiency syndrome. Epilepsia 2002; 43:941-945.
16. Leary LD, Wang D, Nordli DR, et al. Seizure characterization and electroencephalographic features in GLUT1 deficiency syndrome. Epilepsia 2003; 44:701-707. This article characterizes distinctive EEG-features associated with GLUT1-DS.
17. Pascual JM, Van Heertum RL, Wang D, et al. Imaging the metabolic footprint of GLUT1 deficiency on the brain. Ann Neurol 2002; 52:458-464. An important study on metabolic brain imaging in GLUT1-DS.
18. Chugani HT, Phelps ME, Mazziotta JC. Positron emission tomography study of human brain functional development. Ann Neurol 1987; 22:487-497.
19. Chugani HT. A critical period of brain development: studies of cerebral glucose utilization with PET. Prev Med 1998; 27:184-188.
20. Klepper J, Garcia-Alvarez M, O'Driscoll KR, et al. Erythrocyte 3-O-methyl-D-glucose uptake assay for diagnosis of glucose-transporter-protein syndrome. J Clin Lab Anal 1999; 13:116-121.
21. Nordli DR Jr, De Vivo DC. The ketogenic diet revisited: back to the future. Epilepsia 1997; 38:743-749.
22. De Vivo DC, Leary L, Wang D. Glucose transporter 1 deficiency syndrome and other glycolytic defects. J Child Neurol 2002; 17 (Suppl 3):S15-S23.
23. Ho YY, Yang H, Klepper J, et al. Glucose transporter type 1 deficiency syndrome (GLUT1-DS): methylxanthines potentiate GLUT1 haploinsufficiency in vitro. Pediatr Res 2001; 50:254-260.
24. Klepper J, Fischbarg J, Vera JC, et al. GLUT1-deficiency: barbiturates potentiate haploinsufficiency in vitro. Pediatr Res 1999; 46:677-683.
25. Klepper J, Florcken A, Fischbarg J, et al. Effects of anticonvulsants on GLUT1-mediated glucose transport in GLUT1 deficiency syndrome in vitro. Eur J Pediatr 2003; 162:84-89. A recent study with therapeutic implications.
26. Naftalin RJ, Afzal I, Cunningham P, et al. Interactions of androgens, green tea catechins and the antiandrogen flutamide with the external glucose-binding site of the human erythrocyte glucose transporter GLUT1. Br J Pharmacol 2003; 140:487-499.
27. Lange P, Gertsen E, Monden I, et al. Functional consequences of an in vivo mutation in exon 10 of the human GLUT1 gene. FEBS Lett 2003; 555:274-278.
28. Klepper J, Monden I, Guertsen E, et al. Functional consequences of the autosomal dominant G272A mutation in the human GLUT1 gene. FEBS Lett 2001; 498:104-109.
29. Hebert DN, Carruthers A. Glucose transporter oligomeric structure determines transporter function: reversible redox-dependent interconversions of tetrameric and dimeric GLUT1. J Biol Chem 1992; 267:23829-23838.
30. Mueckler M, Caruso C, Baldwin SA, et al. Sequence and structure of a human glucose transporter. Science 1985; 229:941-945.
31. Cornford EM, Hyman S, Cornford ME, et al. GLUT1 glucose transporter activity in human brain injury. J Neurotrauma 1996; 13:523-536.
32. Klepper J, Vera JC, De Vivo DC. Deficient transport of dehydroascorbic acid in the glucose transporter protein syndrome. Ann Neurol 1998; 44:286-287.
33. Heilig C, Brosius F, Siu B, et al. Implications of glucose transporter protein type 1 (GLUT1)-haplodeficiency in embryonic stem cells for their survival in response to hypoxic stress. Am J Pathol 2003; 163:1873-1885.
34. Heilig CW, Saunders T, Brosius FC 3rd, et al. Glucose transporter-1-deficient mice exhibit impaired development and deformities that are similar to diabetic embryopathy. Proc Natl Acad Sci U S A 2003; 100:15613-15618. A current mouse model of GLUT1 deficiency.
35. Brown GK. Glucose transporters: structure, function and consequences of deficiency. J Inherit Metab Dis 2000; 23:237-246.